BridgeBio's Approach to Gene Therapy & Nearing the Clinic
We love to hear from our listeners. Send us a message.
BridgeBio's CEO of Gene Therapy, Dr. Eric David, explains the company's gene therapy programs for Canavan disease and congenital adrenal hyperplasia, their manufacturing plans, and the platform underpinning their novel approach to gene therapy.
Create your
podcast in
minutes
It is Free